Dare Bioscience reports Q2 2026 results as first direct product launchesAug 13Quarterly updateDare Bioscience, Inc.
Results posted for onapristone-anastrozole trial in refractory endometrial cancerJul 17Trial updateanastrozoleContext Therapeutics Inc.
Sign inSign in